在瘤学中,对剂量检测研究设计的概率视角
1Biostatistics Innovation Group, Gilead Sciences, Foster City, California, USA.
Pharmaceutical statistics
|December 18, 2024
概括
本研究引入了概括概率比 (GLR) 来评估瘤学临床试验中剂量转换决策的统计证据. 基于GLR的设计提供了一个统一的框架来比较方法并改善最大耐受剂量 (MTD) 估计.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
背景情况:
- 在瘤学中,剂量确定研究使用基于剂量限制性毒性 (DLT) 事件的上下剂量转换规则.
- 评估对剂量转换决策的统计证据,特别是超过目标DLT率,至关重要.
研究的目的:
- 引入通用概率比 (GLR) 来量化剂量转换决策的统计证据.
- 开发一个统一的框架来比较和理解现有的剂量升级/降级间隔设计.
主要方法:
- 将GLR应用于单剂量概率,创建基于GLR的间隔设计,以目标DLT率和GLR切割点为目标.
- 将GLR方法扩展到使用非参数 (例如,同位素回归) 或参数模型的联合概率.
主要成果:
- 基于GLR的间隔设计为现有设计提供了概率解释和统一的比较框架.
- 使用GLR进行间隔设计的比较揭示了差异,激励了减少过度处理的替代方案,同时保持MTD估计的准确性.
- 同位体GLR的性能与单剂量GLR相似;当模型正确时,基于节模型的GLR可以提高MTD估计的准确性.
结论:
- 在瘤学试验中,GLR为基于证据的剂量转换决策提供了强大的统计框架.
- 基于GLR的设计有助于开发更有效,更准确的方法来确定最大耐受剂量 (MTD).
- 这种方法提高了对各种剂量发现设计的比较和理解,从而改善了临床试验策略.
更多相关视频
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
Dose-Response Relationship: Overview
2.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.9K
Odds Ratio
104
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
104
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Study Designs in Epidemiology
180
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
180
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K


